Transcription of Data Integrity 483’s / Warning Letters
{{id}} {{{paragraph}}}
Example: biology
Data Integrity 483’s / Warning Letters
483 s / Warning Letters related to QC data Integrity vis-a-vis Regulatory Expectations Ranjit BarshikarQuality by Design / cGMP Metrics .. US QC / Mfg. relatedLagging metrics: Batch Failure Rate Right First Time Out of Specification (OOS) / Laboratory Failure Investigation RatesLeading metrics: Quality System Effectiveness Process Capability Quality Culture Index Quality Culture IndexUS FDA Surprise Inspections .. Until now, FDA s inspections of Indian pharma plants have always been with prior notice. The surprise checks and aggressive surveillance are being considered because of instances of fabrication of documents and human errors.
“483’s / Warning letters related to QC Data Integrity vis-a-vis Regulatory Expectations” Ranjit Barshikar Quality by Design / cGMP Consultant ranjitbarshikar@gmail.com ranjit@qbdinternational.com
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: